AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017
Mar 31, 2017
30583_dirs_2017-03-31_6ea2ebe9-4f6c-45c6-98b3-77a9dda2ca75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-03-29
Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-29 | Common Stock | S | 3890 | $89.15 | Disposed | 51532 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.
F2: All shares were sold at the same price.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19